Early detection and successful therapy of fulminant chlamydia pneumoniae myocarditis.
We report a case involving a young female patient with Chlamydia pneumoniae myocarditis who required assist device therapy for acute heart failure. Early diagnosis was provided by endomyocardial biopsy, and tailored antibiotic therapy facilitated quick recovery of myocardial function. This is the first case to report detecting C pneumoniae as the pathogen responsible for fulminant myocarditis while the patient was still alive and to report long-term follow-up data.
Hoefer
Daniel
D
Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria.
Poelzl
Gerhard
G
Kilo
Juliane
J
Hoermann
Christoph
C
Mueller
J Ludwig
JL
Laufer
Guenther
G
Antretter
Herwig
H
D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001706:Biopsy; D002443:Ceftriaxone / Q000627:therapeutic use; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification* / Q000472:pathogenicity*; D017548:Echocardiography, Transesophageal; D004917:Erythromycin / Q000627:therapeutic use; D015199:Extracorporeal Membrane Oxygenation / Q000295:instrumentation / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006353:Heart-Assist Devices; D006801:Humans; D009205:Myocarditis / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D002443:Ceftriaxone